Skip to main content

Adagene Inc.

ADAG
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001818838

In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Adagene Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of ADAG: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders25135+11
Shares3.30M199.6K19.3M+16.2M (+521.2%)
Value$9.70M$782.5K$81.0M+$72.1M (+808.3%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (16)

Institutions that held Adagene Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to ADAG in Q2 2026
InstitutionSharesValue% of portfolio
Jupiter Topco LLC6,666,666$28.1M0.01%
Deerfield Management Company, L.P. (Series C)2,666,666$11.2M0.12%
Siren, L.L.C.2,666,666$11.2M0.23%
Squadron Capital Management LLC1,250,000$5.25M1.80%
Citadel Advisors LLC506,934$2.13M0.00%
Birchview Capital, LP240,000$1.01M0.47%
Moneta Group Investment Advisors LLC200,000$840.0K0.01%
Pathstone Holdings, LLC199,610$838.4K0.00%
Goldman Sachs Group Inc105,598$443.5K0.00%
Marshall Wace, LLP69,100$290.2K0.00%
HRT Financial LP21,735$91.0K0.00%
XTX Topco Ltd12,272$51.5K0.00%
Two Sigma Investments, LP11,953$50.2K0.00%
Huntington National Bank2,464$10.3K0.00%
Wells Fargo & Company1,513$6.36K0.00%
Tower Research Capital LLC (TRC)1,058$4.44K0.00%

Sold out (5)

Institutions that held Adagene Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of ADAG in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Persistent Asset Partners Ltd35,126$137.7K
Alyeska Investment Group, L.P.20,710$81.2K
Nomura Holdings Inc14,710$57.7K
EverSource Wealth Advisors, LLC2,473$9.69K
Barclays PLC400$1.57K

Not filed for Q2 2026 yet (1)

Institutions that held Adagene Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ADAG in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Mill Creek Capital Advisors, LLC199,610$782.5K